Life Technologies loses exec to Dx startup

Life Technologies ($LIFE) is losing one of its executives to a diagnostics startup, as the Carlsbad, CA, company's planned $13.6 billion sale to Thermo Fisher Scientific ($TMO) in Massachusetts reaches its final stages. Murali Prahalad left Life to become CEO of Epic Sciences in San Diego, a private cancer diagnostics company. He had been with Life since 2005, most recently as vice president of corporate strategy. Epic is developing diagnostic tests designed to use circulating tumor cells to assess the aggressiveness of a patient's cancer and help personalize the subsequent treatment. Item

Suggested Articles

The FDA has announced a series of actions aimed at limiting the use of power morcellators in gynecologic surgeries.

J&J launched a virtual clinical study to gauge whether Apple’s iPhone and ECG-enabled smartwatch can help reduce the risk of stroke and catch AFib.

The Salt Lake City-based developer said its Logix Smart test is now available to be exported from Utah to countries requiring the CE Mark.